InvestorsHub Logo

biopharm

10/19/19 9:13 PM

#332121 RE: eb0783 #332104

Eb, thanks for the updates ...greatly appreciated. I wonder how Eli Lilly is doing with Loxo Oncology as they are only the 2nd behind Merck for FDA approval based upon tissue etc not location of tumor

Lots of PS Targeting research involved as CGI Cancer Genetics Inc ( that aided Keytruda) has ties in Loxo

Cancer Genetics Inc and HTG Molecular deal as CGI scooped up by Interpace Diagnostics ...which was scooped up by Ampersand

Ampersand was brought in for Avid CDMO as Biomarkers were KEY...much more interest from new IIS that will not settle